Paper11248552
Combinatorial control of the specificity of protein tyrosine phosphatases.
Tonks NK and 1 other. Curr Opin Cell Biol, 2001. Cited by 426 papers, by iCite.
Cite this record
ConductScience Library. Combinatorial control of the specificity of protein tyrosine phosphatases. Papers, record 11248552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11248552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Tyrosine Phosphatases | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Humans | |
| Protein Structure, Tertiary | |
| Substrate Specificity |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 DK50654 | NIDDK NIH HHS | United States | P01DK050654 | PubMed and NIH | NIH RePORTER |
| P30 C45508 | PHS HHS | United States | PubMed | PubMed | |
| P50 HL56993 | NHLBI NIH HHS | United States | P50HL056993 | PubMed and NIH | NIH RePORTER |
| R01 CA49152 | NCI NIH HHS | United States | R01CA049152 | PubMed and NIH | NIH RePORTER |
| R01 CA53840 | NCI NIH HHS | United States | R01CA053840 | PubMed and NIH | NIH RePORTER |
| R01 DK50693 | NIDDK NIH HHS | United States | R01DK050693 | PubMed and NIH | NIH RePORTER |
| R01 GM55989 | NIGMS NIH HHS | United States | R01GM055989 | PubMed and NIH | NIH RePORTER |
Cited by155
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 426 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41292192 | Distal Mutations Rewire Allosteric Networks to Control Substrate Specificity in PTP1B. | Biochemistry | 2025 | https://conductscience.org/library/papers/41292192 | PubMed |
| 40355891 | Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology. | J Transl Med | 2025 | https://conductscience.org/library/papers/40355891 | PubMed |
| 40320551 | Leveraging AI to explore structural contexts of post-translational modifications in drug binding. | J Cheminform | 2025 | https://conductscience.org/library/papers/40320551 | PubMed |
| 40166291 | Leveraging AI to Explore Structural Contexts of Post-Translational Modifications in Drug Binding. | bioRxiv | 2025 | https://conductscience.org/library/papers/40166291 | PubMed |
| 39926046 | Elevated PTPN3 expression in type 2 diabetes mellitus: Insights from genetic and experimental analyses. | Biomed Rep | 2025 | https://conductscience.org/library/papers/39926046 | PubMed |
| 38504984 | Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull's eye for targeted therapy? | Front Immunol | 2024 | https://conductscience.org/library/papers/38504984 | PubMed |
| 37692032 | Prognostic value and immunological role of PTPN21 in pan-cancer analysis. | Cent Eur J Immunol | 2023 | https://conductscience.org/library/papers/37692032 | PubMed |
| 36755813 | STAT5b: A master regulator of key biological pathways. | Front Immunol | 2022 | https://conductscience.org/library/papers/36755813 | PubMed |
| 36064958 | Tyrosine phosphatase activity is restricted by basic charge substituting mutation of substrates. | Sci Rep | 2022 | https://conductscience.org/library/papers/36064958 | PubMed |
| 35829702 | Dissecting protein tyrosine phosphatase signaling by engineered chemogenetic control of its activity. | J Cell Biol | 2022 | https://conductscience.org/library/papers/35829702 | PubMed |
| 35434626 | Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/35434626 | PubMed |
| 34830476 | Pseudophosphatases as Regulators of MAPK Signaling. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830476 | PubMed |
| 33795832 | Grb2 binding induces phosphorylation-independent activation of Shp2. | Commun Biol | 2021 | https://conductscience.org/library/papers/33795832 | PubMed |
| 32760098 | Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model. | PLoS One | 2020 | https://conductscience.org/library/papers/32760098 | PubMed |
| 32727223 | The multi-functional eyes absent proteins. | Crit Rev Biochem Mol Biol | 2020 | https://conductscience.org/library/papers/32727223 | PubMed |
| 32596156 | Shp1 in Solid Cancers and Their Therapy. | Front Oncol | 2020 | https://conductscience.org/library/papers/32596156 | PubMed |
| 32156083 | Synthesis, In Vitro Evaluation and Molecular Docking of the 5-Acetyl-2-aryl-6-hydroxybenzo[b]furans against Multiple Targets Linked to Type 2 Diabetes. | Biomolecules | 2020 | https://conductscience.org/library/papers/32156083 | PubMed |
| 31553163 | Profiling Protein Tyrosine Phosphatase Specificity with Self-Assembled Monolayers for Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Peptide Arrays. | ACS Comb Sci | 2019 | https://conductscience.org/library/papers/31553163 | PubMed |
| 30267440 | The molecular details of cytokine signaling via the JAK/STAT pathway. | Protein Sci | 2018 | https://conductscience.org/library/papers/30267440 | PubMed |
| 30092354 | Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain. | Cell Signal | 2018 | https://conductscience.org/library/papers/30092354 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11248552
GET https://conductscience.org/api/papers/v1/11248552/cited_by?page=2